Biotech

All Articles

AstraZeneca spends CSPC $100M for preclinical heart problem drug

.AstraZeneca has settled CSPC Pharmaceutical Team $100 million for a preclinical heart attack medica...

Zephyrm looks for Hong Kong IPO to money stage 3 cell therapy tests

.Zephyrm Bioscience is gusting toward the Hong Kong stock market, filing (PDF) for an IPO to stake s...

Frazier Life Sciences gets $630M for little, mid-cap biotechs

.Frazier Lifespan Sciences has actually sourced an additionally $630 million for its own fund paid a...

GigaGen garners as much as $135M BARDA money to hammer botox

.Antitoxin fanatic GigaGen, a subsidiary of Spanish biopharma Grifols, is ramping up its technician ...

GPCR organization Septerna files for IPO on toughness of preclinical records

.Septerna is about to learn how a biotech without "any type of purposeful professional records" fare...

Kurma finalizes initially $154M haul for largest biotech fund as yet

.European VC organization Kurma Partners has actually introduced its own most current biotech fund, ...

Prothena promotes one director while yet another leaves behind-- Chutes &amp Ladders

.Invite to today's Chutes &amp Ladders, our roundup of notable leadership hirings, shootings and ret...

Editas cashes in on Vertex Cas9 licensing liberties for $57M

.Versus the scenery of a Cas9 license fight that declines to pass away, Editas Medicine is cashing i...

Ultragenyx tweaks genetics treatment dosing to call up efficiency

.A minority of patients taking Ultragenyx Pharmaceutical's Wilson condition genetics therapy UX701 h...

Biopharma unemployment price stabilizes in Q3: Tough Biotech evaluation

.As summer months heat turns to cool winds, hopes that this year would certainly deliver common mark...